Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.30 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21369792 | 0.97 | KDM4E (0.33) | ATMKDM4EL3MBTL1CYP11B1ALOX5 | |
| SCHEMBL16904480 | 0.92 | ATM (0.42) | ATMKDM4EL3MBTL1MEN1KMT2A | |
| SCHEMBL21369888 | 0.91 | CYP11B1 (0.36) | ATMKDM4EL3MBTL1CYP11B1ALOX5 | |
| SCHEMBL21370172 | 0.90 | CYP11B1 (0.40) | ATMKDM4EL3MBTL1CYP11B1ALOX5 | |
| SCHEMBL21370156 | 0.90 | ATM (0.41) | ATMKDM4EL3MBTL1MEN1KMT2A | |
| SCHEMBL21369842 | 0.90 | ATM (0.41) | ATMKDM4EL3MBTL1MEN1KMT2A | |
| SCHEMBL21369887 | 0.90 | CYP11B1 (0.36) | ATMKDM4EL3MBTL1CYP11B1ALOX5 | |
| SCHEMBL21370174 | 0.89 | ATM (0.42) | ATMKDM4EL3MBTL1MEN1KMT2A | |
| SCHEMBL21369843 | 0.88 | KDM4E (0.39) | ATMKDM4EL3MBTL1MEN1KMT2A | |
| SCHEMBL21369963 | 0.88 | CYP11B1 (0.40) | ATMKDM4EL3MBTL1CYP11B1ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190288215-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | SOULBRAIN CO., LTD. (KR) | 2019-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190288215-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | CRY1, CYP1A1, CYP1B1 | ATM 3568/4885KDM4E 2473/4885L3MBTL1 1787/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.